Status: Recruiting
Tissue-Engineered Construct Based on Amniotic Membrane and Calcium Alginate for Cesarean Section Wound Healing
This clinical trial aims to evaluate the safety and efficacy of an experimental tissue-engineered construct (TEC) based on amniotic membrane and calcium alginate for promoting epithelialization and improving scar quality in patients after cesarean section. The study will assess both biological and clinical indicators of wound healing, including cytokine dynamics (IL-6, IL-10), ultrasound characteristics, and patient-reported outcomes.
Participants needed: 100
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: Asfendiyarov Kazakh National Medical UniversityUpdated: Nov 21, 2025Locations: 1
Eligibility criteria
Women aged 18 years and older. [+4]
Acute infectious, autoimmune, or oncological diseases. [+4]